Laura Jopson

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Letter: Beyond advanced fibrosis-The critical need for assessing NITs performance in identifying F2-F3 fibrosis. Authors' reply.

Letter: Beyond advanced fibrosis-The critical need for assessing NITs performance in identifying F2-F3 fibrosis. Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: September 10, 2024

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply.

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: August 30, 2024

How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease?

How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease?

Journal: Alimentary pharmacology & therapeutics

Published: February 26, 2024

Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?

Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?

Journal: Canadian journal of gastroenterology & hepatology

Published: June 13, 2022

Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated Mice.

Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated Mice.

Journal: The American journal of pathology

Published: May 20, 2022

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study.

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study.

Journal: EBioMedicine

Published: November 23, 2021

Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle.

Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle.

Journal: Frontline gastroenterology

Published: October 05, 2021

The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.

The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.

Journal: Hepatology (Baltimore, Md.)

Published: January 08, 2021

Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison.

Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison.

Journal: Journal of translational autoimmunity

Published: December 30, 2020

Curious case of gut dysmotility.

Curious case of gut dysmotility.

Journal: Gut

Published: September 10, 2019

Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.

Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.

Journal: Digestive diseases and sciences

Published: March 01, 2018

Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial.

Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial.

Journal: Hepatology (Baltimore, Md.)

Published: February 13, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026